Why Aditxt Inc. (ADTX) Went Down On Thursday?

We recently published a list of 10 Stocks Fall Behind Amid Market Optimism. In this article, we are going to take a look at where Aditxt Inc. (NASDAQ:ADTX) stands against other stocks that fall behind amid market optimism.

Wall Street’s main indices rebounded from hefty losses on Wednesday after President Donald Trump announced that the US will pause the imposition of higher tariffs on 75 countries for 90 days.

In a post on Truth Social, Trump said that more than 75 countries have called to negotiate and have not retaliated in any way.

“I have authorized a 90-day PAUSE, and a substantially lowered Reciprocal Tariff during this period, of 10%, also effective immediately,” he noted.

Following the announcement, the Dow Jones jumped by 7.87 percent, the S&P 500 surged by 9.52 percent, and the tech-heavy Nasdaq soared by 12.16 percent.

Despite the overall market optimism, 10 companies, predominantly in the biopharmaceutical sector, registered losses amid the lack of fresh developments to spark buying appetite.

In this article, we listed Wednesday’s 10 worst performers and detailed the reasons behind their drop.

To come up with the list, we considered only the stocks with over $1 million in trading volume.

A researcher holding a 3D printed organ in front of a microscope.

Aditxt Inc. (NASDAQ:ADTX)

Aditxt saw its share prices decline for a fourth straight day on Wednesday, shedding 8.81 percent to end at $3 apiece as investors sold off positions despite news that it had officially regained compliance with the Nasdaq’s minimum bid price requirement.

The Nasdaq invited ADTX for a hearing on April 22, 2025 to supposedly explain its non-compliance, but it has already been canceled after regaining the compliant status.

“We are pleased to have regained compliance with Nasdaq’s listing requirements. We continue to remain focused on advancing our progress towards addressing autoimmunity, cancer, and other pressing health challenges,” said ADTX co-founder and CEO Amro Albanna.

In other news, ADTX said it entered into a financial agreement with Evofem Biosciences for a $1.5-million investment in the latter in exchange for a convertible note and a warrant to acquire shares.

The investment was in line with the two companies’ planned merger strategy which has been in the works since March 23.

Overall, ADTX ranks 8th on our list of stocks that fall behind amid market optimism. While we acknowledge the potential of ADTX as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than ADTX but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.